To determine the expression signature of OPN3 at the protein level, immunohistochemistry (IHC) staining of the above five types of cancers (BLCA, GBM, LGG, LIHC and STAD) was conducted (Fig. 3). This evidence concerns the gene OPN3 and glioblastoma.